Bioavailability of zinc glycinate in comparison with zinc sulphate in the presence of dietary phytate in an animal model with Zn labelled rats.
The objective of this study was to quantify the bioavailability of zinc (Zn) from sulphate and glycinate as representatives of inorganic and organic zinc sources. The semi-synthetic basal diet contained 2 microg/g of native Zn and was fortified with pure sodium-phytate (8 g/kg) in order to simulate conditions of common cereal-based meals. The basal diet was supplemented with either 53 microg/g of Zn from sulphate (control) or 10 microg/g of Zn from either sulphate (ZnSulphate) or glycinate (ZnGly). Twenty-four (65)Zn-labelled, growing rats weighing 133 g were allotted to the three diets (eight animals per treatment) and were kept pair-fed to ZnSulphate for 15 days. Zn contents in blood plasma, femur and whole body, as well as, plasma alkaline phosphatase activities were reduced compared with control indicating a zinc deficiency in ZnSulphate and ZnGly treatment. This allowed their differentiation in zinc bioavailability. True absorption of dietary Zn was significantly higher in ZnGly than in ZnSulphate (51% vs. 44%) while losses of endogenous faecal Zn and urinary Zn were not affected to a quantitatively relevant extent (mean: 17% and 2% of intake). This resulted in a +30% significantly improved Zn retention for ZnGly (33% vs. 25%) and a lower severity on Zn deficiency symptoms compared with ZnSulphate. Metabolic utilization accounted for 95% of absorbed dietary Zn for both Zn sources. Overall, the bioavailability of zinc glycinate was significantly superior by 16% to zinc sulphate (49% vs. 42%), mainly because of a higher absorptive potential at presence of a strong anti-nutritive component (phytate) in the diet.
Schlegel
P
P
Pancosma SA, Le Grand-Saconnex/GE, Switzerland.
Windisch
W
W